Cargando…
Unproven cell interventions in Poland and the exploitation of European Union law on advanced therapy medicinal products
The global threat of unproven “stem cell therapies” develops despite the repeated statements of scientific organizations and regulatory agencies warning about the improper rationale, lack of effectiveness, and potential health risks of such commercial activities. Here, this problem is discussed from...
Autores principales: | Dulak, Józef, Pecyna, Marlena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444563/ https://www.ncbi.nlm.nih.gov/pubmed/37390824 http://dx.doi.org/10.1016/j.stemcr.2023.05.017 |
Ejemplares similares
-
Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions
por: Horner, Claire, et al.
Publicado: (2018) -
Unproven stem cell interventions: A global public health problem requiring global deliberation
por: Master, Zubin, et al.
Publicado: (2021) -
Bluetongue Epidemiology in the European Union
por: Saegerman, Claude, et al.
Publicado: (2008) -
Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area
por: van den Wijngaard, Cees C, et al.
Publicado: (2017) -
Prevention of human rabies: a challenge for the European Union and the European Economic Area
por: Gossner, Céline M, et al.
Publicado: (2020)